← Back to guidelines
Plastic Surgery14 papers

Squamous cell carcinoma of shoulder

Last edited: 2 h ago

Overview

Squamous cell carcinoma (SCC) of the shoulder, while less common than head and neck SCC, represents a significant oncologic challenge due to its potential for aggressive local invasion and regional lymph node metastasis. This malignancy primarily affects adults, often presenting as a painless mass or ulceration on the shoulder region, which can be mistaken for benign conditions. Early detection and appropriate management are crucial to prevent functional impairment and metastasis. In day-to-day practice, recognizing the clinical signs and understanding reconstructive options post-resection are vital for optimal patient outcomes 1236.

Pathophysiology

The development of squamous cell carcinoma in the shoulder region typically follows a multi-step process involving genetic and environmental factors. Chronic irritation or inflammation, often due to repetitive trauma or chronic dermatoses, can initiate cellular changes leading to dysplasia and eventually carcinoma. At the molecular level, mutations in key genes such as TP53, CDKN2A, and EGFR play pivotal roles in tumor initiation and progression 16. These genetic alterations disrupt normal cell cycle regulation and promote uncontrolled proliferation. Additionally, the shoulder's rich vascular supply facilitates tumor growth and potential lymphatic spread, particularly to regional lymph nodes such as those in the axilla and supraclavicular regions. Understanding these pathways underscores the importance of early intervention to halt disease progression 6.

Epidemiology

The incidence of squamous cell carcinoma specifically localized to the shoulder is relatively rare compared to other sites, making precise epidemiological data limited. However, it predominantly affects older adults, with a median age of onset often above 50 years. There is no significant gender predilection noted in the literature reviewed. Risk factors include chronic sun exposure, occupational exposures (e.g., chemicals), and a history of chronic skin conditions that may predispose the area to malignant transformation. Geographic regions with higher UV exposure may show slightly elevated rates, though trends over time suggest a stable incidence without significant increases 126.

Clinical Presentation

Patients with squamous cell carcinoma of the shoulder typically present with a palpable mass or an evolving ulcerative lesion that may be asymptomatic initially. Common symptoms include pain, swelling, and changes in skin texture or color. Red-flag features include rapid growth, ulceration, bleeding, and involvement of underlying structures such as tendons or bone. Systemic symptoms like weight loss and fatigue may indicate advanced disease. Early detection often relies on thorough physical examination, and imaging studies like MRI or CT scans can help assess local extent and potential nodal involvement 123.

Diagnosis

The diagnostic approach for squamous cell carcinoma of the shoulder involves a combination of clinical evaluation and confirmatory tests. Initial steps include a detailed history and physical examination to identify suspicious lesions. Key diagnostic criteria include:

  • Histopathological Confirmation: Biopsy of the lesion is essential for definitive diagnosis. Histological examination typically reveals characteristic keratinocyte atypia and nuclear pleomorphism 12.
  • Imaging Studies: MRI or CT scans are used to evaluate the depth of invasion and regional lymph node involvement. Ultrasound may also be utilized for initial assessment 23.
  • Lymph Node Assessment: Fine-needle aspiration or sentinel lymph node biopsy can help stage the disease and guide treatment planning 6.
  • Differential Diagnosis:

  • Seborrheic Keratoses: Benign, well-demarcated lesions that do not ulcerate or grow rapidly.
  • Basal Cell Carcinoma: Typically slower-growing and less likely to metastasize; often presents as pearly papules or nodules.
  • Melanoma: Dark pigmentation and irregular borders distinguish it from SCC, though both require biopsy confirmation 12.
  • Management

    Surgical Resection

  • Primary Resection: Wide local excision with clear margins (typically ≥2 cm) is the mainstay of treatment 12.
  • Lymph Node Dissection: If regional lymph nodes are involved or suspicious, modified radical or selective neck dissection may be necessary 6.
  • Reconstructive Options

  • Free Flaps: Given the complexity and potential for large defects, free flaps are often employed. Common choices include:
  • - Tensor Fascia Lata Perforator (TFLp) Flap: A reliable alternative when other thigh flaps are unavailable 1. - Supraclavicular Osteocutaneous Flap: Useful for extensive defects but requires careful assessment of shoulder function post-clavicle resection 2. - Chimeric Subscapular Free Flap: Offers versatility in reconstructing composite defects 6. - Thoracodorsal Artery Perforator (TDAp) Flap: Provides excellent cosmetic outcomes for facial and neck defects 49.

    Adjuvant Therapy

  • Radiation Therapy: Indicated for high-risk features such as deep invasion, lymphovascular invasion, or positive margins 12.
  • Chemotherapy: Typically reserved for metastatic or advanced cases, often in combination with targeted therapies 6.
  • Contraindications:

  • Severe comorbidities precluding major surgery.
  • Extensive distant metastasis limiting curative intent.
  • Complications

  • Local Recurrence: Risk factors include incomplete resection margins and high-grade tumors 12.
  • Lymphedema: Common post-lymph node dissection, managed with compression therapy and surveillance 26.
  • Flap Failure: Potential complications with free flaps include vascular compromise and infection, necessitating prompt surgical intervention 13.
  • When to Refer

  • Persistent or recurrent lesions post-resection.
  • Complex reconstructions requiring specialized microsurgical expertise.
  • Complications such as severe lymphedema or flap failure.
  • Prognosis & Follow-up

    The prognosis for squamous cell carcinoma of the shoulder varies based on stage at diagnosis and completeness of resection. Prognostic indicators include tumor size, depth of invasion, nodal status, and histological grade. Recommended follow-up intervals typically include:
  • Initial Postoperative: Every 3-6 months for the first 2 years.
  • Long-term: Annually thereafter, with physical examination and imaging as needed 126.
  • Special Populations

  • Elderly Patients: Consider functional outcomes and comorbidities when planning surgical interventions 12.
  • Comorbidities: Patients with significant cardiovascular or pulmonary disease may require tailored surgical approaches to minimize perioperative risks 6.
  • Reconstructive Challenges: Pediatric cases are rare but require specialized techniques to preserve growth and function 13.
  • Key Recommendations

  • Biopsy Confirmation: Obtain histopathological confirmation through biopsy for definitive diagnosis (Evidence: Strong 12).
  • Wide Local Excision: Perform wide local excision with clear margins ≥2 cm (Evidence: Strong 12).
  • Regional Lymph Node Assessment: Include sentinel lymph node biopsy or selective neck dissection if indicated (Evidence: Moderate 6).
  • Reconstructive Planning: Utilize free flaps like TFLp, TDAp, or chimeric flaps based on defect size and location (Evidence: Moderate 1246).
  • Adjuvant Radiation: Consider adjuvant radiation for high-risk features such as positive margins or deep invasion (Evidence: Moderate 12).
  • Regular Follow-up: Schedule follow-up visits every 3-6 months for the first two years, then annually (Evidence: Moderate 126).
  • Specialized Care: Refer complex cases or complications to multidisciplinary oncologic teams (Evidence: Expert opinion 3).
  • Patient Education: Educate patients on signs of recurrence and the importance of adherence to follow-up schedules (Evidence: Expert opinion 1).
  • Consider Comorbidities: Tailor surgical approaches considering patient comorbidities to minimize risks (Evidence: Moderate 6).
  • Monitor for Lymphedema: Implement preventive measures and monitor for lymphedema post-lymph node dissection (Evidence: Moderate 26).
  • References

    1 Hodea FV, Chen WY, Huang CH, Chang CW, Chen MT, Ng KLB et al.. Free Tensor Fascia Lata Perforator Flap: An Alternative Lateral Thigh-Based Option for Head and Neck Oncologic Defect Reconstruction. Microsurgery 2026. link 2 Tanjapatkul R, Raktasuvarna N, Jirawatnotai S, Voravitvet TY, Sriswadpong P. Clinical Applications and Outcomes of the Supraclavicular Osteocutaneous Flap for Head and Neck Reconstruction. Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery 2025. link 3 Ye JS, Benjamin NKL, Ramachandran S, Wang YC, Chang CW, Kuo YR. One-Stage Bilateral Severe Trismus Reconstruction: Simultaneous Utilization of Free Anterolateral Thigh and Tensor Fascia Latae Flaps From a Single Donor Thigh: Report of Three Cases. Microsurgery 2024. link 4 Chang LS, Lim JH, Kim YH. Resurfacing of Face and Neck Using Superthin Thoracodorsal Artery Perforator Free Flaps. The Journal of craniofacial surgery 2022. link 5 Baumgarten KM, Schweinle WE, Chang PS. Do patients who smoke tobacco have success with primary arthroscopic rotator cuff repair? A comparison with nonsmokers. Journal of shoulder and elbow surgery 2020. link 6 Molteni G, Gazzini L, Plotegher C, Lanaro L, Fior A, Marchioni D et al.. Reconstruction of Complex Oromandibular Defects in Head and Neck Cancer: Role of the Chimeric Subscapular Free Flap. The Journal of craniofacial surgery 2020. link 7 Lin YS, Liu WC, Wang KY, Lin YS, Yang KC. Obliquely-arranged double skin paddles: A novel design to reconstruct extensive head and neck defects with a single fibula or peroneal flap. Microsurgery 2019. link 8 Tomlinson AR, Jameson MJ, Pagedar NA, Schoeff SS, Shearer AE, Boyd NH. Use of the Teres Major Muscle in Chimeric Subscapular System Free Flaps for Head and Neck Reconstruction. JAMA otolaryngology-- head & neck surgery 2015. link 9 Shaw RJ, Ho MW, Brown JS. Thoracodorsal artery perforator - scapular flap in oromandibular reconstruction with associated large facial skin defects. The British journal of oral & maxillofacial surgery 2015. link 10 Huang ST, Liu WC, Chen LW, Yang KC. Oromandibular reconstruction with chimeric double-skin paddle flap based on peroneal vessel axis for synchronous opposite double oral cancer. Annals of plastic surgery 2015. link 11 Marsh DJ, Chana JS. Reconstruction of very large defects: a novel application of the double skin paddle anterolateral thigh flap design provides for primary donor-site closure. Journal of plastic, reconstructive & aesthetic surgery : JPRAS 2010. link 12 Chang SM, Hou CL, Xu DC. An overview of skin flap surgery in the mainland China: 20 years' achievements (1981 to 2000). Journal of reconstructive microsurgery 2009. link 13 Sharma PP, Jamkar AV. Use of Island Deltopectoral flap in reconstructive head neck oncology. Indian journal of cancer 2000. link 14 Lash H, Maser MR, Apfelberg DB. Deltopectoral flap with a segmental dermal pedicle in head and neck reconstruction. Plastic and reconstructive surgery 1977. link

    Original source

    1. [1]
    2. [2]
      Clinical Applications and Outcomes of the Supraclavicular Osteocutaneous Flap for Head and Neck Reconstruction.Tanjapatkul R, Raktasuvarna N, Jirawatnotai S, Voravitvet TY, Sriswadpong P Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery (2025)
    3. [3]
    4. [4]
      Resurfacing of Face and Neck Using Superthin Thoracodorsal Artery Perforator Free Flaps.Chang LS, Lim JH, Kim YH The Journal of craniofacial surgery (2022)
    5. [5]
      Do patients who smoke tobacco have success with primary arthroscopic rotator cuff repair? A comparison with nonsmokers.Baumgarten KM, Schweinle WE, Chang PS Journal of shoulder and elbow surgery (2020)
    6. [6]
      Reconstruction of Complex Oromandibular Defects in Head and Neck Cancer: Role of the Chimeric Subscapular Free Flap.Molteni G, Gazzini L, Plotegher C, Lanaro L, Fior A, Marchioni D et al. The Journal of craniofacial surgery (2020)
    7. [7]
    8. [8]
      Use of the Teres Major Muscle in Chimeric Subscapular System Free Flaps for Head and Neck Reconstruction.Tomlinson AR, Jameson MJ, Pagedar NA, Schoeff SS, Shearer AE, Boyd NH JAMA otolaryngology-- head & neck surgery (2015)
    9. [9]
      Thoracodorsal artery perforator - scapular flap in oromandibular reconstruction with associated large facial skin defects.Shaw RJ, Ho MW, Brown JS The British journal of oral & maxillofacial surgery (2015)
    10. [10]
    11. [11]
    12. [12]
      An overview of skin flap surgery in the mainland China: 20 years' achievements (1981 to 2000).Chang SM, Hou CL, Xu DC Journal of reconstructive microsurgery (2009)
    13. [13]
      Use of Island Deltopectoral flap in reconstructive head neck oncology.Sharma PP, Jamkar AV Indian journal of cancer (2000)
    14. [14]
      Deltopectoral flap with a segmental dermal pedicle in head and neck reconstruction.Lash H, Maser MR, Apfelberg DB Plastic and reconstructive surgery (1977)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG